Search Articles

View query in Help articles search

Search Results (1 to 8 of 8 Results)

Download search results: CSV END BibTex RIS


Engaging Men of Diverse Racial and Ethnic Groups With Advanced Prostate Cancer in the Design of an mHealth Diet and Exercise Intervention: Focus Group Study

Engaging Men of Diverse Racial and Ethnic Groups With Advanced Prostate Cancer in the Design of an mHealth Diet and Exercise Intervention: Focus Group Study

[Asian American focus group] “I previously had a gym membership...Since COVID, I’m in lockdown...Most of my exercise are either going out for a jog, a mile jog or walking the dog or cycling, getting on a bike and going out for a 10-miler or something like that. Occasional jump roping and shooting hoops and yard work.” [White focus group] “Then when the radiation started...every day was a struggle.

Elizabeth Y Wang, Hala T Borno, Samuel L Washington III, Terence Friedlander, Sylvia Zhang, Evelin Trejo, Erin L Van Blarigan, June M Chan, Salma Shariff-Marco, Alexis L Beatty, Stacey A Kenfield

JMIR Cancer 2023;9:e45432

Feasibility and Acceptability of a Physical Activity Tracker and Text Messages to Promote Physical Activity During Chemotherapy for Colorectal Cancer: Pilot Randomized Controlled Trial (Smart Pace II)

Feasibility and Acceptability of a Physical Activity Tracker and Text Messages to Promote Physical Activity During Chemotherapy for Colorectal Cancer: Pilot Randomized Controlled Trial (Smart Pace II)

Between March 15, 2018, and March 20, 2020, a total of 44 participants were randomized 1:1 to intervention or control, using a computer-generated randomization scheme created by a blinded study statistician (LZ). The 45th interested and eligible participant was not randomized owing to an enrollment hold as a result of the COVID-19 pandemic. The randomization scheme was uploaded to REDCap, and the study research coordinator used REDCap to determine a given participant’s assigned intervention arm.

Erin L Van Blarigan, Anand Dhruva, Chloe E Atreya, Stacey A Kenfield, June M Chan, Alexandra Milloy, Iris Kim, Paige Steiding, Angela Laffan, Li Zhang, Sorbarikor Piawah, Yoshimi Fukuoka, Christine Miaskowski, Frederick M Hecht, Mi-Ok Kim, Alan P Venook, Katherine Van Loon

JMIR Cancer 2022;8(1):e31576

Perceptions of Older Men Using a Mobile Health App to Monitor Lower Urinary Tract Symptoms and Tamsulosin Side Effects: Mixed Methods Study

Perceptions of Older Men Using a Mobile Health App to Monitor Lower Urinary Tract Symptoms and Tamsulosin Side Effects: Mixed Methods Study

The participants received daily questionnaires through the mobile app at a prespecified time of their choice, and the questionnaire data from all participants were then collected in a secure cloud-based database made accessible to the research team; participants could review their own results throughout the study period. Additional study design details were previously published [9], and results pertaining to the PERSONAL pilot study itself will be published in a separate manuscript.

Elizabeth Y Wang, Benjamin N Breyer, Austin W Lee, Natalie Rios, Akinyemi Oni-Orisan, Michael A Steinman, Ida Sim, Stacey A Kenfield, Scott R Bauer

JMIR Hum Factors 2021;8(4):e30767

Tracking Lower Urinary Tract Symptoms and Tamsulosin Side Effects Among Older Men Using a Mobile App (PERSONAL): Feasibility and Usability Study

Tracking Lower Urinary Tract Symptoms and Tamsulosin Side Effects Among Older Men Using a Mobile App (PERSONAL): Feasibility and Usability Study

However, whether older men are able and willing to use a mobile app to track their LUTS and medication side effects, particularly while receiving chronic α1a-blocker therapy, represents a knowledge gap. In this paper, we report the results of a 2-week pilot study using the PERSONAL mobile app to monitor daily LUTS severity and medication side effects among older men receiving chronic tamsulosin therapy.

Austin W Lee, Stacey A Kenfield, Elizabeth Y Wang, Anthony Enriquez, Akinyemi Oni-Orisan, Michael A Steinman, Ida Sim, Benjamin N Breyer, Scott R Bauer

JMIR Form Res 2021;5(12):e30762

Web-Based Lifestyle Interventions for Prostate Cancer Survivors: Qualitative Study

Web-Based Lifestyle Interventions for Prostate Cancer Survivors: Qualitative Study

However, there remains to be a lack of data on the specific types and quantities of intervention components needed to change behavior. Thus, we developed a trial [36] to assess the feasibility and acceptability of a web-based intervention for men with prostate cancer.

Elizabeth Y Wang, Rebecca E Graff, June M Chan, Crystal S Langlais, Jeanette M Broering, Justin W Ramsdill, Elizabeth R Kessler, Kerri M Winters-Stone, Erin L Van Blarigan, Stacey A Kenfield

JMIR Cancer 2020;6(2):e19362

Effect of Increasing Levels of Web-Based Behavioral Support on Changes in Physical Activity, Diet, and Symptoms in Men With Prostate Cancer: Protocol for a Randomized Controlled Trial

Effect of Increasing Levels of Web-Based Behavioral Support on Changes in Physical Activity, Diet, and Symptoms in Men With Prostate Cancer: Protocol for a Randomized Controlled Trial

For optimal engagement, there is a need to provide appropriate content, accommodations, and reinforcement in a way that can successfully promote behavior change [51]. The internet provides a potentially scalable and economical way of delivering lifestyle interventions to cancer survivors [52]. There is 1 Web-based trial (Prostate 8) focused on diet, exercise, and not smoking that has been fully enrolled and will be published soon (NCT02470936).

Kerri M Winters-Stone, Stacey A Kenfield, Erin L Van Blarigan, Esther L Moe, Justin W Ramsdill, Kimi Daniel, Greta Macaire, Kellie Paich, Elizabeth R Kessler, Omer Kucuk, Theresa W Gillespie, Karen S Lyons, Tomasz M Beer, Jeanette M Broering, Peter R Carroll, June M Chan

JMIR Res Protoc 2018;7(11):e11257

The Fitbit One Physical Activity Tracker in Men With Prostate Cancer: Validation Study

The Fitbit One Physical Activity Tracker in Men With Prostate Cancer: Validation Study

We selected the Fitbit One for this study because it was one of the most advanced Fitbit models available in 2013; it remains a widely available and popular tracker in 2017. The Fitbit One is a 3-axis, accelerometer-based, physical activity tracker that measures steps, floors climbed, distance traveled, calories burned, physical activity, and sleep. The device is small (0.76”×0.38”×1.89”) and can be clipped to a belt, tight-fitting clothing, or a pocket.

Erin L Lynn Van Blarigan, Stacey A Kenfield, Lucy Tantum, Lisa A Cadmus-Bertram, Peter R Carroll, June M Chan

JMIR Cancer 2017;3(1):e5